1. Home
  2. RAPP vs PSEC Comparison

RAPP vs PSEC Comparison

Compare RAPP & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$30.97

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Logo Prospect Capital Corporation

PSEC

Prospect Capital Corporation

HOLD

Current Price

$2.51

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAPP
PSEC
Founded
2022
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2024
2004

Fundamental Metrics

Financial Performance
Metric
RAPP
PSEC
Price
$30.97
$2.51
Analyst Decision
Strong Buy
Sell
Analyst Count
5
1
Target Price
$47.80
$2.50
AVG Volume (30 Days)
425.2K
3.6M
Earning Date
11-06-2025
02-09-2026
Dividend Yield
N/A
21.69%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$680,752,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.43
$2.45
52 Week High
$42.27
$4.47

Technical Indicators

Market Signals
Indicator
RAPP
PSEC
Relative Strength Index (RSI) 58.13 36.51
Support Level $28.03 $2.45
Resistance Level $31.52 $2.71
Average True Range (ATR) 1.99 0.06
MACD 0.10 -0.01
Stochastic Oscillator 68.57 11.88

Price Performance

Historical Comparison
RAPP
PSEC

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About PSEC Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Share on Social Networks: